FDA warns Amgen over misleading cancer drug promotion
The FDA has warned Amgen that a promotional video for its colorectal cancer drug Vectibix (panitumumab) is false or misleading because it omitted risk information and the drug’s limitations of use, according to an Aug. 12 warning letter posted to the agency’s website. The agency’s Office of Prescription Drug Promotion said the video, which Amgen […] The post FDA warns Amgen over misleading cancer drug promotion appeared first on Becker's Hospital Review | Healthcare...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.